CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy President and CEO bought 5,000 shares at $7.83 ($39,141)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Unregistered share sale
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 4,819 shares (grant or award)
- 4 Grant or award Director acquired 4,819 shares (grant or award)
- 4 Grant or award Director acquired 4,819 shares (grant or award)
- 4 Grant or award Director acquired 1,204 shares (grant or award)
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 70,467 shares at an average $8.43 ($594,375)
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 3/A Insider 3/A
- 3/A Insider 3/A
Page 58 of 62 · 1,224 filings